Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127157961 | 12715796 | 1 | I | 20160817 | 20160901 | 20160906 | 20160906 | PER | US-PFIZER INC-2016416611 | PFIZER | 85.00 | YR | M | Y | 0.00000 | 20160906 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127157961 | 12715796 | 1 | PS | IRINOTECAN HCL | IRINOTECAN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 324 MG, ONCE EVERY 2 WEEKS | U | 20571 | 324 | MG | SOLUTION FOR INFUSION | ||||||
| 127157961 | 12715796 | 2 | C | ATORVASTATIN | ATORVASTATIN | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 127157961 | 12715796 | 3 | C | BACLOFEN. | BACLOFEN | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 127157961 | 12715796 | 4 | C | LORAZEPAM. | LORAZEPAM | 1 | 0.5 MG, AS NEEDED EVERY 6 HOURS | 0 | .5 | MG | |||||||||
| 127157961 | 12715796 | 5 | C | ONDANSETRON | ONDANSETRON | 1 | 8 MG, AS NEEDED | 0 | 8 | MG | |||||||||
| 127157961 | 12715796 | 6 | C | ONDANSETRON | ONDANSETRON | 1 | 0 | ||||||||||||
| 127157961 | 12715796 | 7 | C | TRIFLUOPERAZINE | TRIFLUOPERAZINETRIFLUOPERAZINE HYDROCHLORIDE | 1 | 10 MG, AS NEEDED | 0 | 10 | MG | |||||||||
| 127157961 | 12715796 | 8 | C | TRIFLUOPERAZINE | TRIFLUOPERAZINETRIFLUOPERAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127157961 | 12715796 | 9 | C | PALONOSETRON | PALONOSETRON | 1 | 0.25 MG, UNK | 0 | .25 | MG | |||||||||
| 127157961 | 12715796 | 10 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 127157961 | 12715796 | 11 | C | LEUCOVORIN /00566701/ | LEUCOVORIN | 1 | Intravenous (not otherwise specified) | 350 MG, UNK | 0 | 350 | MG | ||||||||
| 127157961 | 12715796 | 12 | C | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 4320 MG, FLUSH FOR 46 HOURS | 0 | 4320 | MG | ||||||||
| 127157961 | 12715796 | 13 | C | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 720 MG, UNK | 0 | 720 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127157961 | 12715796 | 1 | Gastric cancer |
| 127157961 | 12715796 | 2 | Blood cholesterol |
| 127157961 | 12715796 | 3 | Hiccups |
| 127157961 | 12715796 | 5 | Nausea |
| 127157961 | 12715796 | 6 | Vomiting |
| 127157961 | 12715796 | 7 | Nausea |
| 127157961 | 12715796 | 8 | Vomiting |
| 127157961 | 12715796 | 9 | Premedication |
| 127157961 | 12715796 | 10 | Premedication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127157961 | 12715796 | Diarrhoea | |
| 127157961 | 12715796 | Oesophageal spasm | |
| 127157961 | 12715796 | Speech disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127157961 | 12715796 | 1 | 20160817 | 0 |